Holen Sie sich die Stockscreener-App
44.72
1.76%
-0.80
Handel nachbörslich:
44.83
0.11
+0.25%
Tonix Pharmaceuticals Holding Corp Aktie (TNXP) Neueste Nachrichten
Is Tonix Pharmaceuticals Holding Corp. a good long term investmentFree Stock Market Return Analysis - Autocar Professional
Tonix Pharmaceuticals Holding Corp. Stock Analysis and ForecastPhenomenal wealth increase - jammulinksnews.com
What analysts say about Tonix Pharmaceuticals Holding Corp. stockExceptional portfolio growth - Autocar Professional
What drives Tonix Pharmaceuticals Holding Corp. stock priceMarket-leading growth rates - jammulinksnews.com
Tonix Pharmaceuticals shares rise 2.00% premarket after launching Move Fibro Forward campaign for fibromyalgia awareness. - AInvest
Tonix Pharmaceuticals Announces the Launch of the “Move - GlobeNewswire
Tonix Pharma Launches Move Fibro Forward Campaign - TipRanks
Tonix Tackles 15-Year Fibromyalgia Treatment Void with Groundbreaking Patient Support Campaign - Stock Titan
Tonix targets August PDUFA date for Fibromyalgia drug candidate, advances mpox vaccine strategy - Proactive financial news
Tonix Pharma Stock Soars After Roping In Former Celgene Corp Executive Joseph Hand: Retail Gets More Positive - MSN
Are TNXP Shares Ready for a Comeback? - StocksToTrade
Tonix Pharma Plans Sales Force for TNX-102 SL - TipRanks
Tonix Pharmaceuticals ($TNXP) Skyrockets 284% in 2025: Earnings Catalysts.... - Investing.com India
Tonix reports TNX-801 vaccine shows promise against mpox By Investing.com - Investing.com South Africa
Tonix Pharmaceuticals Shares Climb on Encouraging TNX-801 Vaccine Results - MSN
Tonix Pharmaceuticals Announces Presentation of New Data on - GlobeNewswire
Tonix Pharma stock up after data for pain drug (TNXP:NASDAQ) - Seeking Alpha
Tonix Pharmaceuticals stock rises on promising TNX-801 vaccine data By Investing.com - Investing.com India
Tonix Pharmaceuticals stock rises on promising TNX-801 vaccine data - Investing.com Australia
Tonix reports TNX-801 vaccine shows promise against mpox - Investing.com
Tonix Pharma Unveils Promising TNX-801 Vaccine Findings - TipRanks
Revolutionary Mpox and Smallpox Vaccine Achieves 100,000-Fold Safety Improvement with Single-Dose Protection - Stock Titan
Tonix Pharmaceuticals Announces On-line Publication of - GlobeNewswire
Tonix Pharmaceuticals' TNX-102 SL: A Breakthrough in Fibromyalgia Treatment and Its Implications for Investors - AInvest
Tonix’s fibromyalgia drug shows positive results in phase 3 trial By Investing.com - Investing.com South Africa
Tonix’s fibromyalgia drug shows positive results in phase 3 trial - Investing.com Australia
Tonix Pharma Publishes Phase 3 Trial Results - TipRanks
Tonix Pharmaceuticals Announces Publication of Positive Phase 3 RESILIENT Trial Data for TNX-102 SL in Fibromyalgia Management - Nasdaq
Tonix Pharmaceuticals Announces On-line Publication of Phase 3 RESILIENT Trial Results of TNX-102 SL for Fibromyalgia in the Peer Reviewed Journal, Pain Medicine - Yahoo Finance
Tonix Pharmaceuticals Announces Efficacy and Safety of Single-Dose TNX-801 Vaccine Against Monkeypox - Quiver Quantitative
Tonix Pharmaceuticals Announces Oral Presentation on Mpox - GlobeNewswire
Breakthrough: New Single-Dose Vaccine Demonstrates 100% Protection Against Deadly Mpox Challenge - Stock Titan
Tonix Pharmaceuticals Announces Peer-Reviewed Publication - GlobeNewswire
Tonix reports promising cancer treatment data in animal models - Investing.com
Tonix Pharmaceuticals Holding Corp.(NasdaqCM: TNXP) added to Russell 3000E Index - MarketScreener
Tonix Pharmaceuticals Joins Elite Russell Indexes Ahead of Major FDA Decision - Stock Titan
Tonix Pharmaceuticals Announces Inclusion in the Russell 3000® and Russell 2000® Indexes - GlobeNewswire
3.32%
1.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):